Literature DB >> 23064669

[Onychomycosis : a crown jewel of dermatology].

H-J Tietz1, P Nenoff.   

Abstract

Onychomycosis is a curable infection disease. It is widespread, but not easy to treat. Because fungal pathogens never induce immunity, the relapse rate of mycoses is generally high. The main causes are residual fungal spores in the nail and the individual susceptibility of the patient, which can hardly be influenced. Crucial for long-term therapeutic success is a sporicidal topical therapy. In severe cases ones also needs long-term, well-tolerated systemic therapy, based on accurate microbiological diagnosis of the causative agent. Presented is a three-step therapeutic approach that is easy to perform, well- tolerated and produces sustained results.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23064669     DOI: 10.1007/s00105-012-2448-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  7 in total

1.  Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs. a standard amorolfine lacquer in healthy subjects.

Authors:  D Monti; U Herranz; L Dal Bo; A Subissi
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-03-26       Impact factor: 6.166

2.  [Fungal nail infections - an update. Part 2 - From the causative agent to diagnosis - conventional and molecular procedures].

Authors:  P Nenoff; G Ginter-Hanselmayer; H-J Tietz
Journal:  Hautarzt       Date:  2012-02       Impact factor: 0.751

3.  [Fungal nail infections--an update: Part 1--Prevalence, epidemiology, predisposing conditions, and differential diagnosis].

Authors:  P Nenoff; G Ginter-Hanselmayer; H-J Tietz
Journal:  Hautarzt       Date:  2012-01       Impact factor: 0.751

4.  Onychomycosis.

Authors:  C Seebacher; J Brasch; D Abeck; O Cornely; I Effendy; G Ginter-Hanselmayer; N Haake; G Hamm; U-Ch Hipler; H Hof; H C Korting; P Mayser; M Ruhnke; K-H Schlacke; H-J Tietz
Journal:  Mycoses       Date:  2007-07       Impact factor: 4.377

5.  An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis.

Authors:  R Baran; A Tosti; I Hartmane; P Altmeyer; J Hercogova; V Koudelkova; T Ruzicka; P Combemale; I Mikazans
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-05-04       Impact factor: 6.166

6.  Stigmatisation in onychomycosis patients: a population-based study.

Authors:  Jacek C Szepietowski; Adam Reich
Journal:  Mycoses       Date:  2008-09-12       Impact factor: 4.377

7.  Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.

Authors:  G Ginter-Hanselmayer; W Weger; J Smolle
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-01-10       Impact factor: 6.166

  7 in total
  2 in total

Review 1.  [Sports-associated dermatophytoses : An overview].

Authors:  P Mayser; W Handrick; P Nenoff
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

Review 2.  [Terbinafine : Relevant drug interactions and their management].

Authors:  A Dürrbeck; P Nenoff
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.